The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use
Author | Hassali, Mohamed Azmi |
Author | Alrasheedy, Alian A. |
Author | McLachlan, Andrew |
Author | Nguyen, Tuan Anh |
Author | AL-Tamimi, Saleh Karamah |
Author | Ibrahim, Mohamed Izham Mohamed |
Author | Aljadhey, Hisham |
Available date | 2016-05-16T10:55:22Z |
Publication Date | 2014-12 |
Publication Name | Saudi Pharmaceutical Journal |
Resource | Scopus |
Identifier | http://dx.doi.org/10.1016/j.jsps.2013.12.017 |
Citation | Hassali, M.A., Alrasheedy, A.A., McLachlan, A., Nguyen, T.A., AL-Tamimi, S.K., Ibrahim, M.I.M., Aljadhey, H. "The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use" (2014) Saudi Pharmaceutical Journal, 22 (6), pp. 491-503. |
ISSN | 1319-0164 |
Abstract | Generic medicines are clinically interchangeable with original brand medicines and have the same quality, efficacy and safety profiles. They are, nevertheless, much cheaper in price. Thus, while providing the same therapeutic outcomes, generic medicines lead to substantial savings for healthcare systems. Therefore, the quality use of generic medicines is promoted in many countries. In this paper, we reviewed the role of generic medicines in healthcare systems and the experiences of promoting the use of generic medicines in eight selected countries, namely the United States (US), the United Kingdom (UK), Sweden, Finland, Australia, Japan, Malaysia and Thailand. The review showed that there are different main policies adopted to promote generic medicines such as generic substitution in the US, generic prescribing in the UK and mandatory generic substitution in Sweden and Finland. To effectively and successfully implement the main policy, different complementary policies and initiatives were necessarily introduced. Barriers to generic medicine use varied between countries from negative perceptions about generic medicines to lack of a coherent generic medicine policy, while facilitators included availability of information about generic medicines to both healthcare professionals and patients, brand interchangeability guidelines, regulations that support generic substitution by pharmacists, and incentives to both healthcare professionals and patients. |
Language | en |
Publisher | Elsevier |
Subject | Generic medicines Generic policy Generic substitution Health system Pharmacists Physicians |
Type | Article |
Pagination | 491-503 |
Issue Number | 6 |
Volume Number | 22 |
Check access options
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Research [1243 items ]